AAA Endoluminal Grafting

A New Frontier In...

Abdominal Aortic Aneurysm Therapy

 

New:  View a Live Web Broadcast of an actual
Endograft Repair of  an Abdominal Aortic Aneurysm... 


Don't have RealPlayer: Download here...



Contents:

Historical Background

Over the last several decades, there have been significant advances in the treatment of vascular disease.  Balloon angioplasty was a breakthrough technology that allowed for the restoration of flow to occluded (blocked) vessels without a major operation and chest incision.  The evolution of stent therapy has improved the success and durability of traditional angioplasty procedures.

 

Recently, a new technique called endoluminal grafting has been introduced. This provides an important alternative for patients requiring treatment of aneurysmal disease, specifically for the exclusion, or confinement, of abdominal aortic aneurysms (AAA's).   An aneurysm describes the enlargement of a blood vessel due to atherosclerosis, hypertension, trauma, or genetic factors.  As aneurysms enlarge, they carry with them the very serious risk of rupture...  a complication that can prove fatal.  The incidence of AAA's is expected to surge in the new millenium as the aging "Baby Boomer" population becomes increasingly at risk for cardiovascular diseases.  Currently, more than 15,000 deaths can be attributed to AAA annually,  making it the 13th leading cause of death in the United States. Abdominal Aortic Aneurysm
 

We at Heart Care Centers of Illinois are excited about this latest breakthrough in vascular disease management.  Affirming our commitment to cutting-edge therapies in the management of cardiac and vascular disease, a number of our physicians are skilled in this new technique. 


Arrow_red.gif (881 bytes) Back to Top

New Catheter-Based Procedure

The conventional surgical approach to the therapy of Abdominal Aortic Aneurysms (AAA's) requires an incision over the abdomen to expose the aorta.  The aneurysm is then clamped off below the renal arteries and above the iliac arteries.  A synthetic graft is placed within the aneurysmal vessel, essentially removing the risk of future rupture.

This major surgery requires a hospital stay of seven to ten days, and full recovery times ranging up to eight weeks.  For some patients with multiple coincident medical problems, major surgery is not an option, and until recently, no alternative treatment was available. 

In 1999, the FDA approved the first minimally invasive devices to repair AAA's:   Medtronic's AneuRx Stent Graft System and Guidant's Ancure Endograft System. These second generation devices demonstrate significant design advantages over initial models.  In fact, the AneuRx procedure has been performed successfully in 92% of patients in an ongoing clinical study. 

Endovascular Therapy for Abdominal Aortic Aneurysms
Utilizing the new catheter-based technique, a small incision is made in the groin and a catheter is guided through the femoral artery to the aneurysm.  Both  X-ray guidance and intravascular ultrasound are employed to measure the aneurysm.  Then, an appropriately sized  endoluminal graft is placed inside the enlarged aorta to exclude blood flow into the aneurysm.  The endovascular procedure requires a hospital stay of only 24-48 hours, and patients are encouraged to walk within a few hours.  Importantly, high-risk patients who  might not be eligible for conventional surgery can often be treated with the endovascular device.

 

Endoluminal grafting will decrease death and disability from AAA's, which are estimated to affect 1.5 million Americans, and are diagnosed in some 200,000 people each year. The newly FDA-approved technology has been shown to cut major complications by 50% and significantly reduce time spent in the hospital by three or four days. 

Arrow_red.gif (881 bytes) Back to Top

Candidates for Endovascular Technique

At the present time, not all patients are candidates for the endovascular technique.  If the aneurysm is too close to the renal arteries, sharply angled, or if the iliac vessels are too small, it may not be possible to deploy the graft.  As with all new technologies, there will be limitations.  In the coming years, as new advancements are made in endoluminal grafting, many more patients will be able to choose this less invasive alternative.  Many experts believe that 70% of AAA's will eventually be treated via a catheter-based approach.



Doctors Skilled in Endovascular Therapy for AAA

  • Robert A. Iaffaldano, M.D. - Medical Director, Cardiac Catheterization Laboratory
  • Ronald E. Stella, M.D.- Director, Cardiac Cath. Lab., MacNeal Hospital
  • For more information, or to make an appointment, please call our
    St. Francis Hospital, Blue Island Office at  (708) 824-1114.

    Arrow_red.gif (881 bytes) Back to Top

    Spacer.gif (73 bytes)


       Copyright© 1998-2007 Heart Care Centers of Illinois.  All Rights Reserved.

    Mission - Services - Offices - Hospitals - Cardiologists - CME Events - Clinical Trials - Risk Test -Home - Search - Links